OP Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History

OP Asset Management’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.04M	Buy	22,295 +14,132	+173%	+$679K	0.01%	588
2026 Q1	$422K	Sell	8,163 -948	-10%	-$48.3K	﹤0.01%	683
2025 Q4	$453K	Buy	+9,111	New	+$443K	0.01%	665
2025 Q2	–	Sell	-26,866	Closed	-$880K	–	843
2025 Q1	$880K	Buy	+26,866	New	+$952K	0.01%	618

Other funds holding SUPN

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

CNAM

Campbell Newman Asset Management Milwaukee, Wisconsin $1.35B AUM 38.87% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

VIM

Villanova Investment Management Wayne, Pennsylvania $105M AUM 9.97% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

OP Asset Management's SUPN Position: Q2 2026 in Review

OP Asset Management increased its Supernus Pharmaceuticals (SUPN) stake by 173% in Q2 2026, buying an estimated $679K and bringing the position to 22,295 shares worth $1.04M. The position accounts for 0.01% of the portfolio, ranked #588.

OP Asset Management first reported a position in SUPN in Q1 2025 and has held it in 4 quarters since. 68 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

OP Asset Management held 22,295 shares of Supernus Pharmaceuticals worth $1.04M as of Q2 2026.
OP Asset Management bought 14,132 Supernus Pharmaceuticals shares in Q2 2026, an estimated $679K.
Supernus Pharmaceuticals made up 0.01% of OP Asset Management's portfolio in Q2 2026, its #588 holding.
OP Asset Management first reported a position in Supernus Pharmaceuticals in Q1 2025 and has held it in 4 quarters since.
68 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on OP Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.